Last reviewed · How we verify
Rosuvastatin, Olmesartan Medoxomil
Rosuvastatin, Olmesartan Medoxomil is a Small molecule drug developed by Daewoong Pharmaceutical Co. LTD.. It is currently in Phase 2 development.
At a glance
| Generic name | Rosuvastatin, Olmesartan Medoxomil |
|---|---|
| Sponsor | Daewoong Pharmaceutical Co. LTD. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Effect of Improving Systolic BP and LDL-C Compared to Conventional Treatments and the Convenience of Taking Medication of Olostar Tab
- Reduction Efficacy of OLOMAX for Blood Pressure and Low-density Lipoprotein Cholesterol in Hypertensive Patients With Dyslipidemia
- Observational Study to Evaluate the Therapeutic Effectiveness and Safety of Olomax Tab
- A Clinical Trial to Evaluate the Efficacy and Safety of Olmesartan/Amlodipine/Rosuvastatin Combination Treatment in Patients With Concomitant Hypertension and Hyperlipidemia (PHASE3)
- Combination of Olmesartan Effect on Myocardial Viability of Patients With Dilated Cardiomyopathy (NA)
- Clinical Trail to Evaluate the Efficacy and Safety of DWJ1451 (PHASE3)
- Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia (PHASE4)
- Clinical Trial to Investigate the Efficacy and Safety of DWJ1351 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rosuvastatin, Olmesartan Medoxomil CI brief — competitive landscape report
- Rosuvastatin, Olmesartan Medoxomil updates RSS · CI watch RSS
- Daewoong Pharmaceutical Co. LTD. portfolio CI
Frequently asked questions about Rosuvastatin, Olmesartan Medoxomil
What is Rosuvastatin, Olmesartan Medoxomil?
Rosuvastatin, Olmesartan Medoxomil is a Small molecule drug developed by Daewoong Pharmaceutical Co. LTD..
Who makes Rosuvastatin, Olmesartan Medoxomil?
Rosuvastatin, Olmesartan Medoxomil is developed by Daewoong Pharmaceutical Co. LTD. (see full Daewoong Pharmaceutical Co. LTD. pipeline at /company/daewoong-pharmaceutical-co-ltd).
What development phase is Rosuvastatin, Olmesartan Medoxomil in?
Rosuvastatin, Olmesartan Medoxomil is in Phase 2.